1 not yet recruiting, 1 recruiting, 1 withdrawn. 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Alendronate 70mg weekly: new trials by email Literature Review of Alendronate 70mg weekly trials Research Report on Alendronate 70mg weekly
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation Alendronate 70mg weekly - Cervix Cancer | Phase 1 / Phase 2 | Not yet recruiting | Dr. Itay GoorAryeh | 65 | 2025-12-01 | 2025-11-24 |
| A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures Alendronate 70mg weekly - Osteoporosis in Post-menopausal Women | Phase 4 | Recruiting | Odense University Hospital | 1400 | 2025-02-21 | 2025-03-07 |
| The Effects of Alendronate After Cure of Primary Hyperparathyroidism Alendronate 70mg weekly - Hyperparathyroidism | Phase 4 | Withdrawn | Columbia University | 2006-07-01 | 2011-11-16 |
Osteoporosis (2) · Hypercalcemia (1) · Hyperparathyroidism (1) · Hyperparathyroidism, Primary (1) · Uterine Cervical Neoplasms (1)
Columbia University (1) · Dr. Itay GoorAryeh (1) · Odense University Hospital (1)
Denmark (1) · United States (1)
Pernille Hermann, MD, PhD. (1) · Shonni J. Silverberg, MD (1)
2023 (1)